Health
Vaccine shows promise against herpes virus: New study demonstrates candidate’s potential to generate antibodies, limit viral shedding – Science Daily
A genetically edited form of a herpes simplex virus has outperformed a leading vaccine candidate in a new study. When challenged with a virulent strain of the sexually…
A genetically edited form of a herpes simplex virus — rewired to keep it from taking refuge in the nervous system and eluding an immune response — has outperformed a leading vaccine candidate in a new study from the University of Cincinnati, Northwestern University and the University of Nebraska-Lincoln.Published Nov. 6 in the journal Nature Vaccines, the study found that vaccinating guinea pigs with the modified live virus significantly increased the production of virus-combating antibodies….
-
Business20 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News16 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business20 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.